Tech Company Financing Transactions
Altea Therapeutics Funding Round
Altea Therapeutics, based in Atlanta, scored $685 thousand in investment from private investors.
Transaction Overview
Company Name
Announced On
10/25/2010
Transaction Type
Debt
Amount
$685,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Transaction amount includes options, warns or other rights to acquire another security. SEC regulatory filing.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
387 Technology Cir. NW 100
Atlanta, GA 30313
USA
Atlanta, GA 30313
USA
Phone
Website
Email Address
Overview
Altea Therapeutics is an emerging private pharmaceutical company focused on developing and commercializing a broad portfolio of pharmaceutical products based on a new class of advanced transdermal patches that deliver sustained therapeutic levels of proteins and water-soluble drugs in a convenient, painless and cost-effective manner.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Tomlinson
VP - Bus. Development
Steven Damon
VP - Finance
Angela Walsh
VP - Product Management
Alan Smith
VP - R & D
Frank Tagliaferri
VP - Regulatory Affairs
Alexander Jacks
Browse more venture capital transactions:
Prev: 10/25/2010: Exagen Diagnostics venture capital transaction
Next: 10/25/2010: RGB Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs